MUTATIONAL ANALYSIS OF THE INTEGRASE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2

被引:190
|
作者
VANGENT, DC [1 ]
GROENEGER, AAMO [1 ]
PLASTERK, RHA [1 ]
机构
[1] NETHERLANDS CANC INST,DIV MOLEC BIOL,PLESMANLAAN 121,1066 CX AMSTERDAM,NETHERLANDS
关键词
RETROVIRUS; INTEGRATION;
D O I
10.1073/pnas.89.20.9598
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purified integrase protein (IN) can nick linear viral DNA at a specific site near the ends and integrate nicked viral DNA into target DNA. We have made a series of 43 site-directed point mutants of human immunodeficiency virus type 2 IN and assayed purified mutant proteins for the following activities: site-specific cleavage of viral DNA (donor cut), integration (strand transfer), and disintegration. In general, the different activities were similarly affected by the mutations. We found three mutations that (almost) totally abolished IN function: Asp-64 --> Val, Asp-116 --> Ile, and Glu-152 --> Leu, whereas 25 mutations did not affect IN function. A few mutations affected the different activities differentially. Near the amino terminus a zinc finger-like sequence motif His-Xaa3-His-Xaa20-30-Cys-Xaa2-Cys is present in all retroviral IN proteins. Two mutations in this region (His-12 --> Leu and Cys-40 --> Ser) strongly inhibited donor cut but had less effect on strand transfer. The central region of IN is most highly conserved between retroviral INs. Three mutants in this region (Asn-117 --> Ile, Asn-120 --> Leu, and Lys-159 --> Val) were inhibited in strand transfer but were inhibited less strongly in donor cut. Mutation of Asn-120 (to glycine, leucine, or glutamate) resulted in changes in integration-site preference, suggesting that Asn-120 is involved in interactions with target DNA. We did not find a mutant in which one activity was lost and the others were unaffected, supporting the notion that IN has only one active site for the catalysis of donor cut and strand transfer.
引用
收藏
页码:9598 / 9602
页数:5
相关论文
共 50 条
  • [1] Mutational scan of the human immunodeficiency virus type 2 integrase protein
    van den Ent, FMI
    Vos, A
    Plasterk, RHA
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (05) : 3916 - 3924
  • [2] HUMAN-IMMUNODEFICIENCY-VIRUS, TYPE-2
    BEKTIMIROV, TA
    [J]. VOPROSY VIRUSOLOGII, 1990, 35 (03) : 180 - 183
  • [3] THE HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE PROTEIN
    VINK, C
    PLASTERK, RHA
    [J]. TRENDS IN GENETICS, 1993, 9 (12) : 433 - 437
  • [4] MUTATIONAL ANALYSIS OF SIMIAN IMMUNODEFICIENCY VIRUS FROM AFRICAN-GREEN MONKEYS AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2
    SHIBATA, R
    ADACHI, A
    SAKAI, H
    ISHIMOTO, A
    MIURA, T
    HAYAMI, M
    [J]. JOURNAL OF MEDICAL PRIMATOLOGY, 1990, 19 (3-4) : 217 - 225
  • [5] INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2
    MARKOVITZ, DM
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) : 211 - 218
  • [6] STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 REV PROTEIN
    DILLON, PJ
    NELBOCK, P
    PERKINS, A
    ROSEN, CA
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (01) : 445 - 449
  • [7] GENETIC-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE PROTEIN
    SHIN, CG
    TADDEO, B
    HASELTINE, WA
    FARNET, CM
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (03) : 1633 - 1642
  • [8] THE SPREAD OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 INTO EUROPE - A GEOGRAPHICAL ANALYSIS
    SMALLMANRAYNOR, M
    CLIFF, A
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1991, 20 (02) : 480 - 489
  • [9] INFECTION BY THE TYPE-2 HUMAN-IMMUNODEFICIENCY-VIRUS IN A PROSTITUTE
    ARMENGOL, P
    VILLENA, MJ
    CABALLERO, E
    JUSTE, C
    [J]. MEDICINA CLINICA, 1995, 104 (04): : 156 - 157
  • [10] NEUROSYPHILIS AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 INFECTION
    SAVALL, R
    CABRE, M
    GRIFOL, M
    [J]. ARCHIVES OF NEUROLOGY, 1992, 49 (05) : 440 - 440